CUMMINS INC reported revenue of $9.46B for the period ended 2026-06-30, +9.4% year on year. Net income was $0.97B, a 10.2% net margin on a 26.1% gross margin. Free cash flow for the period was $1.25B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | $9.46B | +9.4% |
| Gross profit | $2.46B | — |
| Operating income | $1.28B | — |
| Net income | $0.97B | +4.3% |
| Gross margin | 26.1% | Net margin 10.2% |
| Revenue Q/Q | +12.6% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | $6.99B | 73.9% |
| R&D | $0.39B | 4.1% |
| SG&A | $0.89B | 9.4% |
| Tax & other | $0.31B | 3.3% |
| Item | Amount |
|---|---|
| Total assets | $35.63B |
| Total liabilities | $21.72B |
| Shareholders' equity | $13.91B |
| Equity / assets | 39.0% |
| Operating cash flow | $1.50B |
| Capital expenditure | $0.25B |
| Free cash flow | $1.25B |
| Cash conversion (OCF / net income) | 161% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
CVS ・ DHR ・ DRI ・ DDOG ・ DVA ・ DECK ・ DE ・ DELL ・ DAL ・ DVN ・ DXCM ・ FANG
Source: SEC EDGAR · This page shows public filing data only, not investment advice. · Browse all companies